Flexion Therapeutics, Inc. (FLXN) CEO Mike Clayman on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19
Flexion Therapeutics (FLXN) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/08/19